loadpatents
name:-0.045902013778687
name:-0.019022941589355
name:-0.0065150260925293
Good; Andrew Charles Patent Filings

Good; Andrew Charles

Patent Applications and Registrations

Patent applications and USPTO patent grants for Good; Andrew Charles.The latest application filed is for "cereblon binders for the degradation of ikaros".

Company Profile
4.15.16
  • Good; Andrew Charles - Watertown MA
  • Good; Andrew Charles - Cambridge MA
  • - Cambridge MA US
  • Good; Andrew Charles - Wallingford CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tricyclic degraders of Ikaros and Aiolos
Grant 11,407,732 - Henderson , et al. August 9, 2
2022-08-09
Cereblon Binders For The Degradation Of Ikaros
App 20210009559 - Henderson; James A. ;   et al.
2021-01-14
Therapeutic compounds and uses thereof
Grant 10,358,437 - Albrecht , et al.
2019-07-23
Therapeutic compounds and uses thereof
Grant 10316023 -
2019-06-11
Therapeutic compounds and uses thereof
Grant 10,308,614 - Albrecht , et al.
2019-06-04
Therapeutic compounds and uses thereof
Grant 10,301,253 - Albrecht , et al.
2019-05-28
Therapeutic compounds and uses thereof
Grant 10,155,764 - Albrecht , et al. Dec
2018-12-18
Therapeutic Compounds And Uses Thereof
App 20180086720 - Albrecht; Brian K. ;   et al.
2018-03-29
Therapeutic Compounds And Uses Thereof
App 20180009735 - Albrecht; Brian K. ;   et al.
2018-01-11
Therapeutic Compounds And Uses Thereof
App 20170334883 - Albrecht; Brian K. ;   et al.
2017-11-23
Therapeutic Compounds And Uses Thereof
App 20170275289 - Albrecht; Brian K. ;   et al.
2017-09-28
Hepatitis C Virus Inhibitors
App 20120330019 - Wang; Xiangdong Alan ;   et al.
2012-12-27
Hepatitis C virus inhibitors
Grant 7,741,281 - D'Andrea , et al. June 22, 2
2010-06-22
Hepatitis C virus inhibitors
Grant 7,592,336 - Sin , et al. September 22, 2
2009-09-22
Hepatitis C virus inhibitors
Grant 7,449,479 - Wang , et al. November 11, 2
2008-11-11
Hepatitis C virus inhibitors
App 20080152619 - Sin; Ny ;   et al.
2008-06-26
Hepatitis C virus inhibitors
Grant 7,323,447 - Sin , et al. January 29, 2
2008-01-29
Hepatitis C virus inhibitors
Grant 7,309,708 - Tu , et al. December 18, 2
2007-12-18
Hepatitis C virus inhibitors
App 20070099825 - D'Andrea; Stanley ;   et al.
2007-05-03
Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
Grant 7,173,004 - McPhee , et al. February 6, 2
2007-02-06
Hepatitis C virus inhibitors
App 20060183694 - Sin; Ny ;   et al.
2006-08-17
Hepatitis C virus inhibitors
App 20060172950 - Wang; Xiangdong Alan ;   et al.
2006-08-03
Hepatitis C virus inhibitors
Grant 7,041,698 - Ripka , et al. May 9, 2
2006-05-09
Hepatitis C virus inhibitors
Grant 6,995,174 - Wang , et al. February 7, 2
2006-02-07
Hepatitis C virus inhibitors
App 20050143316 - Tu, Yong ;   et al.
2005-06-30
Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus
App 20050090432 - McPhee, Fiona ;   et al.
2005-04-28
Heterocyclicsulfonamide hepatitis C virus inhibitors
Grant 6,869,964 - Campbell , et al. March 22, 2
2005-03-22
Inhibitors of hepatitis C virus
Grant 6,867,185 - Campbell , et al. March 15, 2
2005-03-15
Hepatitis C virus inhibitors
App 20040106559 - Wang, Xiangdong Alan ;   et al.
2004-06-03
Heterocyclicsulfonamide hepatitis C virus inhibitors
App 20040072761 - Campbell, Jeffrey Allen ;   et al.
2004-04-15
Hepatitis C virus inhibitors
App 20040048802 - Ripka, Amy ;   et al.
2004-03-11
Inhibitors of hepatitis C virus
App 20040038872 - Campbell, Jeffrey Allen ;   et al.
2004-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed